Sarah Krepp, the Chief Human Resource Officer at Liquidia Corp (NASDAQ:LQDA), has executed a significant divestment of company equity, selling 7,864 shares of common stock on July 13, 2026. The transaction resulted in a total proceeds value of $562,360, with the shares disposed of at prices fluctuating between $71.39 and $71.52 per share. According to regulatory filings, these sales were facilitated through a Rule 10b5-1 trading plan, a pre-arranged framework adopted by Ms. Krepp on December 15, 2023. Footnotes within the filing clarify that the primary purpose of these sales was to cover tax obligations linked to the settlement of restricted stock units (RSUs) and performance stock units (PSUs). These equity awards were originally granted to Ms. Krepp during the period extending from January 2024 through July 2025.
This executive sale occurs as Liquidia Corp experiences substantial market appreciation. The stock has surged 427% over the trailing twelve months, currently trading at $76.47. This valuation corresponds to a market capitalization of $6.83 billion. Despite this robust price action, analysis suggests the stock may remain undervalued relative to its intrinsic Fair Value, positioning it among the opportunities identified in undervalued stock lists. For comprehensive valuation metrics and financial modeling, detailed Pro Research Reports are available for LQDA and over 1,400 other US equities.
Leading up to the July 13 sale, Ms. Krepp engaged in a preceding transaction on July 10, 2026, acquiring 3,179 shares of Liquidia Corp common stock. These shares were obtained through the conversion of performance stock units (PSUs) on a one-for-one basis, requiring no cash payment. The underlying PSUs were part of a grant issued on January 11, 2025, with an initial vesting portion occurring on January 11, 2026, and the remainder scheduled to vest quarterly over the subsequent three years. Following the recent sales, Ms. Krepp’s direct holdings in Liquidia Corp common stock total 117,178 shares. This aggregate figure includes a substantial volume of unvested RSUs and PSUs derived from various grants executed between January 2024 and January 2026.
On the corporate index front, Liquidia Corporation was officially added to the S&P SmallCap 600 Index, effective June 22. This inclusion was determined by S&P Dow Jones Indices based on the company’s market capitalization, liquidity, and profitability criteria. The index addition reflects the company’s evolving scale within the small-cap segment.
Analyst coverage presents diverging perspectives on the equity. BofA Securities recently downgraded Liquidia Technologies from a Buy to a Neutral rating. However, the firm concurrently raised its price target from $64 to $79. The downgrade rationale centered on a more balanced risk-reward profile following the stock’s significant gains earlier in the year. In contrast, H.C. Wainwright raised its price target for Liquidia to $75 while maintaining a Buy rating. This adjustment was influenced by a recent Supreme Court ruling involving Hikma Pharmaceuticals and Amarin, which carries favorable implications for Liquidia’s ongoing legal proceedings. Similarly, Raymond James reiterated a Strong Buy rating with a $68 price target, also citing the positive impact of the Supreme Court decision on the company’s legal positioning.